FDA Issues Safety Alert for Impella Left-Sided Blood Pump
By Physician’s Briefing Staff HealthDay Reporter
MONDAY, April 1, 2024 -- The U.S. Food and Drug Administration has issued a warning regarding a heart pump that could perforate a wall in the left ventricle if used incorrectly.
The left-sided Impella heart pump is made by Abiomed, a subsidiary of Johnson & Johnson MedTech, and has already been linked to 129 injuries and 49 deaths.
"The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death," the statement said, although it adds that "this recall is a correction, not a product removal."
The advisory informs those implanting the Impella devices about revised instructions for use, including "carefully position the pump catheter during operative procedures."
"During operations, the Impella device could cut through the wall of the left ventricle," the company warned in its statement. "The use of the affected Impella pumps may cause serious adverse health consequences, including left ventricle perforation or free wall rupture, hypertension, lack of blood flow, and death."
According to the latest Abiomed advisory, anyone undergoing a procedure using Impella left-sided blood pumps should be aware of the new instructions for use, especially people with heart disease, the elderly, and women.
But Public Citizen, a consumer advocacy group, issued a statement calling for a full ban on the devices. Despite dozens of severe injuries and deaths, "the FDA has allowed them to remain in use," the group said. "Moreover, there are serious and ongoing concerns about whether there are clinically meaningful survival benefits that outweigh the risks of these left ventricular assist devices."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
TUESDAY, Oct. 29, 2024 -- Clinicians fail to rescue female patients with complications after high-risk vascular and cardiac surgeries more often than male patients, according to a...
Extracorporeal Blood Purification Can Cut Cardiac Surgery-Associated AKI
FRIDAY, Oct. 11, 2024 -- For patients undergoing nonemergent cardiopulmonary bypass (CPB), use of an extracorporeal blood purification (EBP) device is associated with a lower rate...
AHA and ACC Update Cardiovascular Management Guideline for Noncardiac Surgery
TUESDAY, Oct. 1, 2024 -- In a clinical practice guideline issued by the American College of Cardiology and American Heart Association, published online Sept. 24 in both...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.